Listing 1 - 10 of 14 | << page >> |
Sort by
|
Choose an application
Ultrasonography --- Synovitis --- methods --- radiography --- Ultrasonography - methods --- Synovitis - radiography
Choose an application
Disease outbreaks --- Poultry diseases --- Synovitis --- Veterinary. --- Etiology.
Choose an application
Poultry Diseases --- Disease Outbreaks --- Synovitis --- etiology --- veterinary
Choose an application
Arthritis, Rheumatoid --- Adenoviridae --- Gene Transfer Techniques --- Genetic Vectors --- Genetic Therapy --- Synovitis --- therapy --- genetics --- drug therapy
Choose an application
CD4 Antigens --- Antibodies, Monoclonal --- Arthritis, Rheumatoid --- Synovitis --- immunology --- therapeutic use --- radionuclide imaging --- prevention & control
Choose an application
Musculoskeletal system --- Hemophilia --- Hemophilia A --- Arthralgia --- Contracture --- Hemarthrosis --- Physical Therapy --- Synovitis --- Appareil locomoteur --- Diseases --- Physical therapy. --- Complications --- rehabilitation. --- therapy. --- methods. --- Maladies --- Physiothérapie --- Physical Therapy Modalities --- Neurological Physiotherapy --- Neurophysiotherapy --- Physical Therapy Techniques --- Physiotherapy (Techniques) --- Modalities, Physical Therapy --- Modality, Physical Therapy --- Physical Therapy Modality --- Physical Therapy Technique --- Physiotherapies (Techniques) --- Physiotherapy, Neurological --- Techniques, Physical Therapy --- Postoperative Care --- Physical Therapist Assistants --- rehabilitation --- therapy --- Physiothérapie --- Locomotor system --- Musculo-skeletal system --- Skeletomuscular system --- Classic hemophilia --- Factor VIII deficiency --- Haemophilia --- Hematophilia --- Hemorrhagic diathesis --- Blood coagulation disorders --- Complications&delete& --- Physical therapy --- Diseases&delete& --- Group Physiotherapy --- Group Physiotherapies --- Physiotherapies, Group --- Physiotherapy, Group --- Physical Therapies --- Therapy, Physical
Choose an application
MicroRNAs (miRNAs) are small noncoding RNAs that are 19–24 nucleotides in length, following maturation. Recent evidence has demonstrated their key role as post-transcriptional regulators of gene expression through the binding of specific sequences within target messenger RNA (mRNA). miRNAs are involved in the synthesis of a very large number of proteins, and it is speculated that they could regulate up to 30% of the human genome. They control virtually every cellular process and are essential for animal development, cell differentiation, and homeostasis. Altered miRNA expression has been linked to such pathological events as inflammatory, degenerative, or autoimmune processes and have been associated with several diseases, including cancer, cardiovascular diseases, diabetes mellitus, and rheumatic and neurological disorders. Recently, miRNAs have been found in many different biological fluids, and this observation suggests the potential of miRNAs as new candidate biomarkers for diagnosis, classification, prognosis, and responsiveness in the treatment of different pathological conditions. Furthermore, the development of therapeutic strategies that involve either restoring or repressing miRNAs expression and activity has attracted much attention. Significant progress has been made in the systems for delivery of miRNAs, even if substantial improvements in this area are still necessary. Although they have been extensively studied, a number of interesting questions regarding the physiological and pathological role of miRNAs have been postulated, and their potential diagnostic and therapeutic role remain yet unanswered. Reactive oxygen species (ROS) are free radical-containing oxygen molecules derived from cellular oxidative metabolism, including enzyme activities and mitochondrial respiration, and play a pivotal role in many cellular functions. Whereas ROS are essential for normal cellular processes, their aberrant production, or failure of the capacity to scavenge excessive ROS, induces an altered redox status with excessive synthesis of free radicals, leading to an imbalance in the redox environment of the cell. The loss of normal ROS levels causes lipid, protein, and DNA damage, which contribute to the development of various pathologies including neurological disorders, rheumatic and cardiovascular diseases, diabetes, and cancer. Increasing evidence highlights that there is crosstalk between miRNAs and components of redox signaling, even if this complex and the characteristics of mutual interaction need to be amply elucidated. Hence, both miRNAs and oxidative stress are involved in the multifactorial development and progression of acute and chronic diseases by influencing numerous signaling and metabolic pathways. The Special Issue entitled "Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology" of the International Journal of Molecular Sciences includes original articles and reviews that provide new insights into the interaction between miRNAs and oxidative stress under normal and pathological conditions which can assist in the development of new therapeutic strategies. Finally, I would like to thank all the authors for their excellent contribution. I hope this Special Issue will provide readers with updated knowledge about the role of miRNAs and oxidative stress in physiology and pathology.
Medicine --- miR-27a-5p --- acute myocardial infarction --- autophagy --- apoptosis --- hypoxia --- MicroRNA (miRNA) --- miR526b --- miR655 --- oxidative stress --- reactive oxygen species (ROS) --- superoxide (SO) --- Thioredoxin Reductase 1 (TXNRD1) --- breast cancer --- nucleic acid medicine --- pancreatic cancer --- clinical trial --- siRNA --- antisense oligonucleotide --- MicroRNA --- signal transduction --- therapeutic target --- miRNAs --- ROS --- noncoding RNA --- microRNA --- long noncoding RNA --- mitochondrial dysfunction --- nitrosative stress. exosome --- cross-talk --- systemic lupus erythematosus --- visfatin --- resistin --- osteoarthritis --- synovial fibroblasts --- synovitis --- NF-κB --- thyroid hormone --- liver cancer --- metabolism --- physiology --- ASH --- NAFLD --- NASH --- HCC --- HCV --- HBV --- endometriosis --- high-grade serous ovarian cancer --- endometriosis-associated ovarian cancer --- epithelial-to-mesenchymal transition --- chemoresistance --- antioxidants --- miRNA --- cancer --- diabetes --- beta cells --- microRNAs --- translation regulation --- neurodegeneration --- Alzheimer’s disease --- Parkinson’s disease --- Huntington’s disease --- ALS --- reactive oxygen species --- redox signaling --- therapeutic tolerance --- therapeutic resistance --- n/a --- Alzheimer's disease --- Parkinson's disease --- Huntington's disease
Choose an application
Temporomandibular Joint Diseases are common and dificult to treat. From diagnosis to treatment, our options are in a broad range. Keeping updated with new technologies is extremely important for researchers and health professionals.
Humanities --- Social interaction --- migraine --- TMD --- Korean National Health Insurance Service --- cohort --- aura --- temporomandibular disorders --- inclination of articular eminence --- temporomandibular joint --- glenoid fossa --- surgery --- synovial tissue --- synovitis --- interleukin --- lumican --- matrix metalloproteinases --- tissue inhibitor of metalloproteinases --- cytokine --- biomarker --- temporomandibular disorder --- rheumatic disease --- juvenile idiopathic arthritis --- rheumatoid arthritis --- inflammatory arthritis --- facial pain --- craniomandibular disorders --- validity and reliability --- questionnaires and survey validity study --- bone scintigraphy --- computed tomography --- condylar hyperplasia --- SPECT --- 99mTc-MDP --- cone-beam computed tomography --- malocclusions --- articular eminence inclination --- electromyography --- temporalis anterior --- masseter muscle --- myofascial pain --- myofascial trigger points --- trapezius --- protein expression --- temporomandibular joint dysfunction --- occlusal appliance --- temporomandibular joint disorders --- muscle pain --- removable appliance --- sleep bruxism --- digital dentistry --- diagnostic bruxism splint --- calcium pyrophosphate dihydrate deposition disease --- pseudogout --- X-ray diffraction --- inductively coupled plasma atomic emission spectroscopy
Choose an application
Autoinflammation, as a relatively new field in clinical rheumatology, has gained an increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows a deeper understanding of closely linked diseases, namely, inflammasomopathies, interferonopathies, Relo-pathies, and proteasome associated syndromes. These insights have not only improved their classification but also helped to identify new treatment targets of pro-inflammatory cytokines, including IL-1ß, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still a high medical need, especially in reliable outcome measures, for confirmation of data from controlled clinical trials and, finally, also for long-term experience from registers. This issue welcomes all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, linking rheumatology even closer to immunology.
gout --- febuxostat --- colchicine --- hepatotoxicity --- prophylaxis --- myositis --- inflammatory idiopathic myopathy --- dysphagia --- aspiration --- pneumonia --- immunoglobulin G4-related orbital disease (IgG4-ROD) --- orbital lymphoma (OL) --- computed tomography (CT) --- Hounsfield unit --- imaging --- autoinflammation --- arthritis --- CAPS --- FCAS --- MWS --- CINCA --- NOMID --- hearing loss --- urticarial-like rash --- autoinflammatory disease --- anti-IL-1 treatment --- rheumatoid arthritis --- synovitis --- neoplasms --- edema --- inflammation --- new genetic variant --- monogenic autoinflammatory syndrome --- diagnostic delay --- anakinra --- damage index --- genetic inheritance --- personalized therapy --- Interleukin-1 --- autoinflammatory diseases --- FMF --- coronavirus --- SARS-CoV-2 antibody response --- adult-onset Still’s disease --- autoinflammatory disorder --- systemic-onset juvenile idiopathic arthritis --- haemophagocytic lymphohistiocytosis --- macrophage activation syndrome --- IFN-γ --- JAK inhibitor --- proliferation --- DNA damage repair --- γH2AX --- PBMCs --- T lymphocytes --- proteasome --- autoimmune --- proteasome-associated autoinflammatory syndrome --- therapy --- IL-1 inhibitors --- NGS --- SURF --- spondyloarthritis --- human leukocyte antigen --- undifferentiated enthesitis and/or arthritis --- ASAS classification criteria --- clinical management --- canakinumab --- cytokines --- n/a --- adult-onset Still's disease
Choose an application
MicroRNAs (miRNAs) are small noncoding RNAs that are 19–24 nucleotides in length, following maturation. Recent evidence has demonstrated their key role as post-transcriptional regulators of gene expression through the binding of specific sequences within target messenger RNA (mRNA). miRNAs are involved in the synthesis of a very large number of proteins, and it is speculated that they could regulate up to 30% of the human genome. They control virtually every cellular process and are essential for animal development, cell differentiation, and homeostasis. Altered miRNA expression has been linked to such pathological events as inflammatory, degenerative, or autoimmune processes and have been associated with several diseases, including cancer, cardiovascular diseases, diabetes mellitus, and rheumatic and neurological disorders. Recently, miRNAs have been found in many different biological fluids, and this observation suggests the potential of miRNAs as new candidate biomarkers for diagnosis, classification, prognosis, and responsiveness in the treatment of different pathological conditions. Furthermore, the development of therapeutic strategies that involve either restoring or repressing miRNAs expression and activity has attracted much attention. Significant progress has been made in the systems for delivery of miRNAs, even if substantial improvements in this area are still necessary. Although they have been extensively studied, a number of interesting questions regarding the physiological and pathological role of miRNAs have been postulated, and their potential diagnostic and therapeutic role remain yet unanswered. Reactive oxygen species (ROS) are free radical-containing oxygen molecules derived from cellular oxidative metabolism, including enzyme activities and mitochondrial respiration, and play a pivotal role in many cellular functions. Whereas ROS are essential for normal cellular processes, their aberrant production, or failure of the capacity to scavenge excessive ROS, induces an altered redox status with excessive synthesis of free radicals, leading to an imbalance in the redox environment of the cell. The loss of normal ROS levels causes lipid, protein, and DNA damage, which contribute to the development of various pathologies including neurological disorders, rheumatic and cardiovascular diseases, diabetes, and cancer. Increasing evidence highlights that there is crosstalk between miRNAs and components of redox signaling, even if this complex and the characteristics of mutual interaction need to be amply elucidated. Hence, both miRNAs and oxidative stress are involved in the multifactorial development and progression of acute and chronic diseases by influencing numerous signaling and metabolic pathways. The Special Issue entitled "Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology" of the International Journal of Molecular Sciences includes original articles and reviews that provide new insights into the interaction between miRNAs and oxidative stress under normal and pathological conditions which can assist in the development of new therapeutic strategies. Finally, I would like to thank all the authors for their excellent contribution. I hope this Special Issue will provide readers with updated knowledge about the role of miRNAs and oxidative stress in physiology and pathology.
miR-27a-5p --- acute myocardial infarction --- autophagy --- apoptosis --- hypoxia --- MicroRNA (miRNA) --- miR526b --- miR655 --- oxidative stress --- reactive oxygen species (ROS) --- superoxide (SO) --- Thioredoxin Reductase 1 (TXNRD1) --- breast cancer --- nucleic acid medicine --- pancreatic cancer --- clinical trial --- siRNA --- antisense oligonucleotide --- MicroRNA --- signal transduction --- therapeutic target --- miRNAs --- ROS --- noncoding RNA --- microRNA --- long noncoding RNA --- mitochondrial dysfunction --- nitrosative stress. exosome --- cross-talk --- systemic lupus erythematosus --- visfatin --- resistin --- osteoarthritis --- synovial fibroblasts --- synovitis --- NF-κB --- thyroid hormone --- liver cancer --- metabolism --- physiology --- ASH --- NAFLD --- NASH --- HCC --- HCV --- HBV --- endometriosis --- high-grade serous ovarian cancer --- endometriosis-associated ovarian cancer --- epithelial-to-mesenchymal transition --- chemoresistance --- antioxidants --- miRNA --- cancer --- diabetes --- beta cells --- microRNAs --- translation regulation --- neurodegeneration --- Alzheimer’s disease --- Parkinson’s disease --- Huntington’s disease --- ALS --- reactive oxygen species --- redox signaling --- therapeutic tolerance --- therapeutic resistance --- n/a --- Alzheimer's disease --- Parkinson's disease --- Huntington's disease
Listing 1 - 10 of 14 | << page >> |
Sort by
|